Simplified Exercise-based Risk Assessment in Lung Cancer

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorLinkoeping University

About this trial

Physiological evaluation is part of the preoperative risk estimation in patients with lung cancer, and it aids in the choice of treatment. Ventilatory efficiency during exercise has emerged as a strong predictor of major postoperative complications, so far determined during a maximal cardiopulmonary exercise test. However, this test is limited by its availability and high cost, due to the requirement of high-technological equipment and advanced expertise. The current project aims to evaluate a simplified and accessible method for risk evaluation before decision on treatment in lung cancer. It builds on recent advances in technology and knowledge and combines a simple, low-intensity cycling test with measurement of ventilatory efficiency (end-tidal carbon dioxide pressure) with a handheld monitor. In a prospective, multi-center design the investigators will include patients evaluated for suspected lung cancer. The main objective is to establish threshold values for end-tidal carbon dioxide associated with low respectively high risk of major complications in patients undergoing surgery. In addition, the study aims to determine if end-tidal carbon dioxide can predict severe side-effects during neoadjuvant or curatively aiming systemic therapy. The project is closely linked to clinical practice, and the results can be easily implemented due to the simple and cost-efficient methodology. the suggested simplified approach would also allow access to physiological evaluation where more advanced methods are unavailable.

Eligibility criteria

Qualifiers

Lung Cancer Diagnosis

Age of at least 18 years

Disqualifiers

Not able to perform cycle ergometer exercise

Not able to understand spoken or written Swedish

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

500 Participants
are grouped into 4 trial groups

Sponsors and collaborators

Linkoeping University

Lead sponsor

Region Östergötland

Collaborator

Region Skane

Collaborator

Region Kalmar län

Collaborator

Region Blekinge

Collaborator

Region Jönköping County

Collaborator